EP Europace

For now, density is a promising biomarker, not a treatment algorithm.

Our third featured paper is by Zee and colleagues published in Europace in August 2026.

The study is entitled Development and Validation of the Gloria AF Stroke, Weighted Risk Score for Patients with Atrial Fibrillation.

Stroke prediction in AF remains challenging.

The EP edge assessment is that this finding supports individualized discussion of arrhythmia risk when prescribing high dose omega-3 therapy balanced against the proven cardiovascular benefits of the specific product and indication.

Two smaller studies examine an interesting direction in physiological atrial pacing.

First, Moulier and colleagues published a Europace study evaluating whether a posterior electrocardiographic lead, V8, could provide a non-invasive measurement of left atrial activation during Buckman bundle pacing.

In two prospective cohorts of 50 patients each, the V8 P-wave downslope measurement correlated strongly with invasive coronary sinus activation, with a correlation coefficient of approximately 0.94. Buckman bundle pacing, shortened activation measurements, and corrected partial interatrial block in 20 of 23 affected patients.

Every week brings another substantial collection of electrophysiology research.

Across the United States and Europe, our reading includes Circulation: Arrhythmia and Electrophysiology, JACC Clinical Electrophysiology, Heart Rhythm, Europace, Pacing and Clinical Electrophysiology, the Journal of Cardiovascular Electrophysiology, and the Journal of Interventional Cardiac Electrophysiology.

To illustrate the volume, suppose these seven journals average ten relevant research articles each per month.

That's seventy papers.